Results 1 to 10 of about 48,511 (262)
Endogenous chondroitin extends lifespan by inhibiting VHA-7-mediated tubular lysosome formation [PDF]
Chondroitin extends lifespan and healthspan in C. elegans, but the relationship between extracellular chondroitin and intracellular anti-aging mechanisms is unknown.
Yukimasa Shibata+9 more
doaj +2 more sources
Enzymatic Production of Chondroitin Oligosaccharides and Its Sulfate Derivatives
Chondroitin sulfate (CS) has a wide range of physiological functions and clinical applications. However, the biosynthesis of chondroitin oligosaccharides (o-CHs) and sulfate derivatives with specific length is always challenging.
Weijiao Zhang+16 more
doaj +1 more source
The gastrointestinal (GI) mucosal barrier is often exposed to inflammatory and erosive insults, resulting in gastric lesions. Glycosaminoglycans (GAGs), such as hyaluronic acid (HA), chondroitin sulfate (CS), and N-acetylglucosamine (NAG) have shown ...
Sara Traserra+5 more
doaj +1 more source
Interaction of β-D-glucopyranuronic acid (GlcA), N-acetyl-β-D-glucosamine (GlcNAc), N-acetyl-β-D-galactosamine (GalNAc) and two natural decameric glycosaminoglycans, hyaluronic acid (HA) and Chondroitin (Ch) with carboxylated carbon nanotubes, were ...
Tomasz Panczyk+4 more
doaj +1 more source
Nutrition and dietary supplements in the prevention of osteoarthritis [PDF]
Optimally balanced diet in order to body weight control in combination with adequate physical activity has an important role in the prevention of degenerative joint disorders.
Vidović Bojana, Đorđević Brižita
doaj +1 more source
Novelties in the treatment of osteoarthritis [PDF]
Goal of osteoarthritis (OA) treatment is to relieve the pain and to reduce the loss of patient's physical functionality. Therapy consists of: nonpharmacological measures, pharmacotherapy and surgery.
Stepanović-Petrović Radica+1 more
doaj +1 more source
Symptomatic delayed-acting drugs (SYSADOA): new applications
The review systematizes modern data indicating effective pain control and a significant improvement in the functional activity of patients suffering from osteoarthritis (OA) using pharmaceutical substances of chondroitin sulfate (CS) and glucosamine (GA).
A. M. Lila+3 more
doaj +1 more source
Chondroitin synthase KfoC is a bifunctional enzyme which polymerizes the capsular chondroitin backbone of Escherichia coli K4, composed of repeated β3N-acetylgalactosamine (GalNAc)-β4-glucuronic acid (GlcA) units. Sugar donors UDP-GalNAc and UDP-GlcA are
Mélanie Leroux+5 more
doaj +1 more source
Osteoarthritis is a very disabling disease that can be treated with both non-pharmacological and pharmacological approaches. In the last years, pharmaceutical-grade chondroitin sulfate (CS) and glucosamine emerged as symptomatic slow-acting molecules ...
Donatella Cimini+11 more
doaj +1 more source
Introduction Musculoskeletal conditions are often characterized by pain, as well as limited physical function. To alleviate pain accompanying musculoskeletal diseases, non-steroidal anti-inflammatory drugs (NSAIDs) and/or paracetamol are used.
Paulina Pluta+2 more
doaj +1 more source